 ALUMIS INCALMS |
| 45.81% | 47.94% | $165.9M | 5.9M | $129.9M | 5.9M | 00.00% | Unchanged |
 CG ONCOLOGY INCCGON |
| 21.17% | 25.08% | $76.7M | 1.1M | $68.0M | 1.0M | +75,000+7.47% | Add |
 DISC MEDICINE INCIRON |
| 7.55% | 8.83% | $27.4M | 374,069 | $23.9M | 374,069 | 00.00% | Unchanged |
| HHIMS & HERS HEALTH INCHIMS |
| 7.07% | 5.65% | $25.6M | 738,151 | $15.3M | 738,151 | 00.00% | Unchanged |
 PHARVARIS N VPHVS |
| 6.34% | 2.02% | $23.0M | 664,142 | $5.5M | 194,125 | +470,017+242.12% | Add |
| EEIKON THERAPEUTICS INCEIKN |
| 4.75% | 5.15% | $17.2M | 1.3M | $14.0M | 1.3M | 00.00% | Unchanged |
| OODYSSEY THERAPEUTICS INCODTX |
| 3.68% | — | $13.3M | 713,105 | $0 | 0 | +713,105 | New Buy |
| LLYELL IMMUNOPHARMA INCLYEL |
| 1.85% | 3.53% | $6.7M | 476,386 | $9.6M | 477,078 | -692-0.15% | Reduce |
 NURIX THERAPEUTICS INCNRIX |
| 1.77% | 1.52% | $6.4M | 265,000 | $4.1M | 265,000 | 00.00% | Unchanged |
